Showing results (771-780 of 781) with videos related to
Sort By:
Pageof 79
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Gastrointestinal stromal tumors, version 2.2014Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 23, 2007
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelinesGeorge D Demetri, Robert S Benjamin, Charles D Blanke, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.Science Translational Medicine|August 15, 2014
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responsesNicholas J Roberts, Linping Zhang, Filip Janku, et al.Cancer|September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma NetworkAnna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.JAMA Oncology|May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case SeriesAnna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.Cancer Treatment Reviews|August 28, 2022
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatmentsSilvia Stacchiotti, Anna Maria Frezza, George D Demetri, et al.Journal of Chemical Information and Modeling|November 5, 2024
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson's Disease Associated ProteinFengling Li, Suzanne Ackloo, Cheryl H Arrowsmith, et al.Pageof 79